| Synonyms: | |
| Status: | Approved (2013) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | J05AP05 |
| UNII: | 9WS5RD66HZ |
| InChI Key | JTZZSQYMACOLNN-VDWJNHBNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C38H47N5O7S2 |
| Molecular Weight | 749.96 |
| AlogP | 5.25 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 156.89 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 52.0 |
| Primary Target | |
|---|---|
| Hepatitis C virus genome polyprotein |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Cysteine protease
Cysteine protease CA clan
Cysteine protease C1A family
|
- | 800 | - | - | - | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | - | - | 0 | - | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | - | - | 0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C, Chronic | 4 | D019698 | ClinicalTrials |
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 923604-59-5 |
| ChEBI | 134743 |
| ChEMBL | CHEMBL501849 |
| DrugBank | DB06290 |
| DrugCentral | 4812 |
| FDA SRS | 9WS5RD66HZ |
| Guide to Pharmacology | 7367 |
| PDB | 30B |
| PubChem | 24873435 |
| SureChEMBL | SCHEMBL826061 |
| ZINC | ZINC000085540268 |